Medtronic FX Effect on Cash increased by 161.5% to $24.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 118.5%, from -$130.00M to $24.00M. Over 2 years (FY 2022 to FY 2025), FX Effect on Cash shows an upward trend with a -9.8% CAGR.
Reflects global exposure; does not indicate operational performance but highlights the sensitivity of cash holdings to currency market volatility.
Represents the impact of fluctuations in foreign currency exchange rates on the company's cash and cash equivalent balan...
Standard for multinational corporations with significant international operations and cash holdings.
cf_fx_effect| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$42.00M | -$9.00M | -$36.00M | -$144.00M | -$122.00M | -$101.00M | $540.00M | -$39.00M | -$175.00M | $44.00M | -$60.00M | $31.00M | $4.00M | -$130.00M | $283.00M | $67.00M | -$39.00M | $24.00M |
| QoQ Change | — | +78.6% | -300.0% | -300.0% | +15.3% | +17.2% | +634.7% | -107.2% | -348.7% | +125.1% | -236.4% | +151.7% | -87.1% | <-999% | +317.7% | -76.3% | -158.2% | +161.5% |
| YoY Change | — | — | — | — | -190.5% | <-999% | >999% | +68.0% | -73.3% | -91.9% | — | +179.5% | +102.3% | -395.5% | +571.7% | +116.1% | <-999% | +118.5% |